FPR2 and hepatocellular carcinoma: This contest allowed us to hypothesize that ANXA1 could affect the macrophages by activating its receptor FPR, as described in the hepatocellular carcinoma where this protein is able to enhance the differentiation into M2 macrophages via FPR2 and supports their expression of IL-10 [49].